Is Universal Health Realty Income Trust (UHT) overvalued or fairly valued?

MarketChacha shows Universal Health Realty Income Trust's valuation in context — a trailing P/E of about 33.0, a price-to-book of about 4.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Universal Health Realty Income Trust's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (2.66×) from reported figures — education, not a rating.

What is Universal Health Realty Income Trust's revenue?

Universal Health Realty Income Trust reported revenue of $99.2M for FY2025, with net profit of $17.6M, per official filings.

What is the share price of Universal Health Realty Income Trust (UHT)?

Universal Health Realty Income Trust last traded at $43.23 (-1.5% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Universal Health Realty Income Trust

UHT · NYSE · Real Estate · United States

$43.23-1.5%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:26 PM

Snapshot

TickerUHT

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

HeadquartersKing of Prussia, United States

Market cap$599.8M

P/E (TTM)33.0

P/B4.1

Volume39.66K

Websitewww.uhrit.com

Filings tracked4

About Universal Health Realty Income Trust

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service-related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust has seventy-seven investments in twenty-one states. It is based in King of Prussia, Pennsylvania. Universal Health Realty Income Trust was incorporated in 1986 in Maryland.

Profile as reported by Yahoo Finance.

Who owns it

Insiders8.4%
Institutions65.8%
Public & other25.8%

269 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.16.29%
Vanguard Portfolio Management LLC6.90%
Vanguard Capital Management LLC4.29%
State Street Corporation4.03%
Geode Capital Management, LLC2.54%
Mirae Asset Global ETFs Holdings Ltd.2.45%
Renaissance Technologies, LLC1.59%
Bank Of New York Mellon Corporation1.49%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion2.66×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend16.1% → 17.8%

Margin has expanded by about 1.6 points — the business is getting more profitable.

Growth qualityrev 2% · PAT 7%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $24.9M

Next fiscal year

Rev $104.3M

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$35.2652-wk range$46.30

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$599.8M

Day change

-1.5%

P/E (TTM)

33.0

P/B

4.1

Div yield

6.84%

Beta

0.85

Revenue (FY2025)

$99.2M

Net margin

17.8%

ROE

11.6%

Revenue CAGR (2y)

+1.9%

Profit CAGR (2y)

+6.9%

EPS (FY2025)

1.27

Net profit (FY2025)

$17.6M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about UHT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$99.2M	$17.6M	1.27	17.8%	11.6%
FY2024	$99.0M	$19.2M	1.39	19.4%	10.7%
FY2023	$95.6M	$15.4M	1.11	16.1%	7.7%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$24.5M	$5.0M	0.36	20.5%
2025Q3	$25.3M	$4.0M	0.29	15.9%
2025Q2	$24.9M	$4.5M	0.32	18.1%
2025Q1	$24.5M	$4.8M	0.34	19.5%
2024Q3	$24.5M	$4.0M	0.29	16.3%
2024Q2	$24.7M	$5.3M	0.38	21.3%
2024Q1	$25.1M	$5.3M	0.38	21.1%
2023Q3	$24.2M	$3.9M	0.28	16.0%
2023Q2	$23.8M	$3.5M	0.25	14.6%
2023Q1	$23.2M	$4.5M	0.32	19.2%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Executive/director change, Shareholder vote results
SEC6/11/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Exhibits
SEC4/27/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/24/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.